Discover
NVNO
enVVeno Medical Corporation
10.83
2 x 7.82
2 x 13.82
bid
ask
+
0.12
1.12%
2 @ 04:00 PM
11.09 +0.26 (2.40%)
| Ytd | -3.56% | |
| 1y | -92.23% |
10.70
day range
10.90
8.67
52 week range
196.70
| Open | 10.70 | Prev Close | 10.71 | Low | 10.70 | High | 10.90 | Mkt Cap | 7.23M |
| Vol | 4.25K | Avg Vol | 10.31K | EPS | -31.20 | P/E | N/A | Forward P/E | -2.45 |
| Beta | 1.22 | Short Ratio | 4.12 | Inst. Own | 29.76% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 10.71 | 200-d Avg | 14.91 | 1yr Est | 18.00 |
| Income Statement | |||
| Operating Expenses | 4.06M | ||
| Research and Development Expense | 2.11M | ||
| Selling, General and Administrative Expense | 1.95M | ||
| Operating Income | -4.06M | ||
| Net Income | -3.85M | ||
| Net Income Common Stock | -3.85M | ||
| Net Income Common Stock (USD) | -3.85M | ||
| Consolidated Income | -3.85M | ||
| Earnings per Basic Share | -5.89 | ||
| Earnings per Basic Share (USD) | -5.89 | ||
| Earnings per Diluted Share | -5.89 | ||
| Earning Before Interest & Taxes (EBIT) | -3.85M | ||
| Earning Before Interest & Taxes (USD) | -3.85M | ||
| Weighted Average Shares | 654.00K | ||
| Weighted Average Shares Diluted | 654.00K | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.60M | ||
| Cash and Equivalents (USD) | 2.60M | ||
| Investments | 22.33M | ||
| Investments Current | 22.33M | ||
| Current Assets | 25.49M | ||
| Property, Plant & Equipment Net | 577.00K | ||
| Total Assets | 26.10M | ||
| Debt Current | 396.00K | ||
| Total Debt | 603.00K | ||
| Current Liabilities | 2.14M | ||
| Debt Non-Current | 207.00K | ||
| Total Liabilities | 2.35M | ||
| Accumulated Retained Earnings (Deficit) | -175.18M | ||
| Shareholders Equity | 23.75M | ||
| Shareholders Equity (USD) | 23.75M | ||
| Assets Non-Current | 608.00K | ||
| Total Debt (USD) | 603.00K | ||
| Liabilities Non-Current | 207.00K | ||
| Trade and Non-Trade Payables | 1.75M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 124.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -468.00K | ||
| Net Cash Flow from Investing | 2.77M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 2.77M | ||
| Net Cash Flow from Operations | -3.24M | ||
| Share Based Compensation | 467.00K | ||